# Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)

> **NCT02803346** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 160 (estimated)

## Conditions studied

- Immunology of Septic Shock

## Interventions

- **OTHER:** Circulating blood (leukocytes)

## Key facts

- **NCT ID:** NCT02803346
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2016-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02803346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02803346, "Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02803346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*